Key result
Diabetes is linked to altered fluid needs and length of stay under cystectomy ERAS protocols.
Why the study?
Diabetic patients undergoing radical cystectomy have higher incidence of complications and longer hospital stay, but the efficacy of ERAS protocol in this group is unclear.
Does the ERAS protocol provide similar postoperative outcomes in diabetic patients compared to non-diabetic patients undergoing radical cystectomy?
Cohort (n=54)
No
Does the ERAS protocol provide similar postoperative outcomes in diabetic patients compared to non-diabetic patients undergoing radical cystectomy?
The ERAS protocol is beneficial and can be safely used in diabetic patients undergoing radical cystectomy to decrease postoperative morbidity.
May support ERAS in diabetic cystectomy patients; leaves open confirmation in randomized trials.
Background: Prevalence of diabetes in surgical patients is 10–40%. They have higher incidence of complications, and longer stay in hospital compared to non-diabetic. Radical cystectomy with urinary diversion is considered one of the high-risk surgeries associated with morbidity and mortality. Enhanced recovery after surgery (ERAS) is an evidence-based multimodal surgical care protocol that improves post-operative outcomes and length of stay (LOS) in patients without diabetes. This study evaluates the evidence on whether diabetic patientswould benefit from ERAS pathway.The aim of the study: was to evaluate the efficacy of ERAS protocol from anesthesia in diabetic patients undergoing radical cystectomy.Patients and methods: This study was carried out in Alexandria main University Hospital on fifty-four adult ASA physical status I, II and III participants of either sex. Participants were scheduled for radical cystectomy surgeries under the effect of general anesthesia, following ERAS protocol, divided into two group diabetic and non-diabetic27 participants each. The ICON device was used to measure the stroke volume variation (SVV) to apply goal-directed fluid therapy (GDFT) for all patients.Measurements: Demographic data, hemodynamic parameters (stoke volume, cardiac index), intra-operative fluid requirement, blood loss, postoperative pain intensity, time of first bowel movement, PH, Bicarbonate level, serum lactate level, heamatocrit and LOS were measured and recorded.Main results: No statistical significant difference was detected between both groups as regard age, sex, weight, vital signs, serum lactate, first bowel movement and VAS. There was statistical significant difference between both groups as regard fluid requirement, and the days of hospital stay.Conclusion: ERAS is a beneficial protocol to improve postoperative outcome in radical cystectomy surgeries, it can be used in diabetic patients to decrease postoperative morbidity and mortality.
No takes yet. Share an insight, caveat, or question.
Ammar et al. (2021) conducted a cohort in Radical cystectomy (n=54). Diabetes mellitus vs. Non-diabetic was evaluated on Fluid requirement and length of hospital stay. Diabetic patients undergoing radical cystectomy with the ERAS protocol had significantly different fluid requirements and length of hospital stay compared to non-diabetic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: